Calamos Advisors’s NEVRO CORP. NVRO Stock Holding History

Calamos Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,010	Closed	-$1.91M	–	975
2020 Q4	$1.91M	Sell	11,010 -2,342	-18%	-$379K	0.01%	639
2020 Q3	$1.86M	Buy	+13,352	New	+$1.78M	0.01%	603
2015 Q1	–	Sell	-13,026	Closed	-$504K	–	734
2014 Q4	$504K	Buy	+13,026	New	+$410K	﹤0.01%	602

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Calamos Advisors's NVRO Position: Q1 2021 in Review

Calamos Advisors sold out of NEVRO CORP. (NVRO) in Q1 2021, closing a stake of 11,010 shares — an estimated $1.91M sold.

Calamos Advisors first reported a position in NVRO in Q4 2014 and held it in 3 quarters. The position peaked at $1.91M in Q4 2020. 204 funds tracked by Wall St. Rank hold NVRO as of Q1 2021.

Calamos Advisors reported no remaining NEVRO CORP. position as of Q1 2021 after selling out during the quarter.
Calamos Advisors sold 11,010 NEVRO CORP. shares in Q1 2021, an estimated $1.91M.
Calamos Advisors first reported a position in NEVRO CORP. in Q4 2014 and held it in 3 quarters.
Calamos Advisors's NEVRO CORP. position peaked at $1.91M in Q4 2020.
204 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2021.

Based on Calamos Advisors's 13F filing for Q1 2021, filed 12 Apr 2021.